Literature DB >> 12238916

New templates for syntheses of ring-fused, C(10) beta-turn peptidomimetics leading to the first reported small-molecule mimic of neurotrophin-3.

Mookda Pattarawarapan1, Maria Clara Zaccaro, Uri H Saragovi, Kevin Burgess.   

Abstract

beta-Turn peptidomimetics 1 were designed to mimic hot spots of neurotrophin-3 (NT-3) and others. Solid-phase syntheses of these were developed, though limitations were encountered with scale-up. Consequently, an alternative design with 2 was investigated. 1 and 2 favored distorted type I beta-turn conformations in solution. It was found that peptidomimetic 2b has NT-3-like neurotrophic activity in cell survival assays, selectively binds the NT-3 receptor TrkC, and induces the tyrosine phosphorylation of the TrkC receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12238916     DOI: 10.1021/jm0255421

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Bivalent diketopiperazine-based tropomysin receptor kinase C (TrkC) antagonists.

Authors:  Jing Liu; Fouad Brahimi; H Uri Saragovi; Kevin Burgess
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

2.  A monovalent agonist of TrkA tyrosine kinase receptors can be converted into a bivalent antagonist.

Authors:  Fouad Brahimi; Jing Liu; Andrey Malakhov; Shafinaz Chowdhury; Enrico O Purisima; Ljubica Ivanisevic; Antoine Caron; Kevin Burgess; H Uri Saragovi
Journal:  Biochim Biophys Acta       Date:  2010-06-19

3.  Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals.

Authors:  Dianjun Chen; Fouad Brahimi; Yu Angell; Yu-Chin Li; Jennifer Moscowicz; H Uri Saragovi; Kevin Burgess
Journal:  ACS Chem Biol       Date:  2009-09-18       Impact factor: 5.100

Review 4.  Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

5.  Combinatorial assembly of small molecules into bivalent antagonists of TrkC or TrkA receptors.

Authors:  Fouad Brahimi; Eunhwa Ko; Andrey Malakhov; Kevin Burgess; H Uri Saragovi
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

6.  A Novel Small Molecule Neurotrophin-3 Analogue Promotes Inner Ear Neurite Outgrowth and Synaptogenesis In vitro.

Authors:  Judith S Kempfle; Marlon V Duro; Andrea Zhang; Carolina D Amador; Richard Kuang; Ryan Lu; Boris A Kashemirov; Albert S Edge; Charles E McKenna; David H Jung
Journal:  Front Cell Neurosci       Date:  2021-07-15       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.